Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Omarigliptin (MK-3102)

Cat. No.: OB0225WX-2764
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, and HPLC.
Size:
Omarigliptin (MK-3102)
Add to basket

Product Overview

Description: Omarigliptin is a competitive and reversible DPP-4 inhibitor (IC50: 1.6 nM; Ki: 0.8 nM) that maintains high selectivity over related proteases like FAP, PEP, and DPP8/9.
Synonym: 1226781-44-7; MK-3102; MK3102; 2H-Pyran-3-amine, 2-(2,5-difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-, (2R,3S,5R)-; (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl)tetrahydro-2H-pyran-3-amine; (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine; (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine; 2H-Pyran-3-amine, 2-(2,5-difluorophenyl)-5-(2,6-dihydro-2-(methylsulfonyl)pyrrolo(3,4-c)pyrazol-5(4H)-yl)tetrahydro-,(2R,3S,5R)-; (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-(2-(methanesulfonyl)-2,6-dihydropyrrolo(3,4- c)pyrazol-5(4H)-yl)oxan-3-amine; (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4- c)pyrazol-5(4H)-yl)tetrahydro-2H-pyran-3-amine; 2H-Pyran-3-amine, 2-(2,5-difluorophenyl)-5-(2,6-dihydro-2-(methylsulfonyl)pyrrolo(3,4- c)pyrazol-5(4H)-yl)tetrahydro-, (2R,3S,5R)-; (2R,3S,5R)-2-(2,5-Difluorophenyl)-5[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine
CAS No.: 1226781-44-7
Compound CID: 46209133
Formula: C17H20F2N4O3S
Formula Weight: 398.43

Specification

Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Omarigliptin is used in metabolic pharmacology as a long-acting DPP-4 inhibitor to investigate the sustained enhancement of incretin hormone activity and its efficacy in glycemic control.

Library Information

Target: DPP
Receptor: DPP4
Pathways: Proteases
Plate Number: L6700-10
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 79 mg/mL; 198.28 mM
ALogP: 1.098
HBA_Count: 4
HBD_Count: 1
Rotatable Bond: 3
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.